Lemonade After Morgan Stanley's Upgrade: Is It a Buy?
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesWhen a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
When a major concert switches venues, fans face more than changed plans. Sting’s Tampa concert moves to Orlando, but ...
Institutional moves can reveal where smart money sees durable cash flow. Learn why ancora advisors opens $148 million...
SpaceX is fueling ambitious AI bets with a massive cash runway. This article weighs that plan against two established...
Awards shine briefly, but investors chase cash flow, growth, and disciplined capital allocation. This guide shows how...
Modine Manufacturing is making waves as a major AI-driven data center cooling deal reshapes its growth path. This dee...
Two March data drops could tease the next cost-of-living adjustment for social security retirees, even though the off...
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
Bit Digital faces shifting crypto markets. This guide breaks down what to watch in the Q1 2026 earnings transcript an...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...